Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatitis C | 17 | 2023 | 1591 | 3.470 |
Why?
|
Hepatitis C, Chronic | 10 | 2023 | 1031 | 3.000 |
Why?
|
Rwanda | 34 | 2022 | 703 | 2.590 |
Why?
|
Antiviral Agents | 14 | 2023 | 2987 | 1.860 |
Why?
|
Hepacivirus | 13 | 2023 | 1379 | 1.480 |
Why?
|
Hepatitis B virus | 4 | 2023 | 513 | 0.900 |
Why?
|
Developing Countries | 10 | 2022 | 2814 | 0.730 |
Why?
|
Hepatitis, Viral, Human | 1 | 2020 | 138 | 0.710 |
Why?
|
Child Mortality | 2 | 2019 | 198 | 0.710 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2018 | 1873 | 0.690 |
Why?
|
Africa South of the Sahara | 4 | 2023 | 724 | 0.650 |
Why?
|
Uridine Monophosphate | 1 | 2018 | 70 | 0.640 |
Why?
|
Poverty | 9 | 2023 | 2660 | 0.610 |
Why?
|
Fluorenes | 1 | 2018 | 160 | 0.610 |
Why?
|
Rural Population | 9 | 2023 | 2210 | 0.600 |
Why?
|
Delivery of Health Care | 6 | 2022 | 5319 | 0.590 |
Why?
|
Health Services Accessibility | 11 | 2023 | 5138 | 0.530 |
Why?
|
HIV Infections | 13 | 2023 | 16718 | 0.490 |
Why?
|
Infant Mortality | 1 | 2018 | 754 | 0.470 |
Why?
|
Patient Acceptance of Health Care | 4 | 2020 | 3023 | 0.470 |
Why?
|
Benzimidazoles | 1 | 2018 | 851 | 0.460 |
Why?
|
Wounds and Injuries | 3 | 2021 | 2400 | 0.440 |
Why?
|
Anti-Retroviral Agents | 3 | 2018 | 1715 | 0.430 |
Why?
|
Hepatitis B | 3 | 2023 | 695 | 0.430 |
Why?
|
Liver Cirrhosis | 3 | 2023 | 1864 | 0.420 |
Why?
|
Viral Load | 7 | 2019 | 3300 | 0.380 |
Why?
|
Carbamates | 2 | 2022 | 196 | 0.370 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2214 | 0.370 |
Why?
|
Cause of Death | 3 | 2019 | 3584 | 0.350 |
Why?
|
HIV | 2 | 2018 | 1604 | 0.350 |
Why?
|
Hospitals, District | 5 | 2024 | 106 | 0.310 |
Why?
|
Anti-HIV Agents | 3 | 2018 | 4256 | 0.290 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4252 | 0.290 |
Why?
|
Autopsy | 3 | 2019 | 1021 | 0.290 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2015 | 2234 | 0.280 |
Why?
|
Primary Health Care | 4 | 2020 | 4556 | 0.280 |
Why?
|
Cost of Illness | 4 | 2022 | 1859 | 0.280 |
Why?
|
Humans | 69 | 2024 | 744220 | 0.280 |
Why?
|
Rural Health Services | 4 | 2021 | 379 | 0.270 |
Why?
|
Hepatitis B, Chronic | 2 | 2023 | 393 | 0.260 |
Why?
|
Public Health | 1 | 2017 | 2603 | 0.250 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4645 | 0.230 |
Why?
|
Interviews as Topic | 3 | 2019 | 2539 | 0.230 |
Why?
|
Quality Assurance, Health Care | 1 | 2013 | 2211 | 0.220 |
Why?
|
Hospitals, Public | 2 | 2023 | 207 | 0.220 |
Why?
|
Health Expenditures | 3 | 2021 | 2348 | 0.220 |
Why?
|
Aminoisobutyric Acids | 1 | 2022 | 38 | 0.210 |
Why?
|
Genotype | 4 | 2022 | 12956 | 0.210 |
Why?
|
Malawi | 2 | 2020 | 282 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3132 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.210 |
Why?
|
Ethiopia | 2 | 2022 | 495 | 0.210 |
Why?
|
Bangladesh | 2 | 2021 | 687 | 0.200 |
Why?
|
Cross Infection | 2 | 2022 | 1416 | 0.200 |
Why?
|
Adult | 27 | 2023 | 214035 | 0.200 |
Why?
|
Kenya | 2 | 2021 | 685 | 0.200 |
Why?
|
Pandemics | 2 | 2021 | 8387 | 0.190 |
Why?
|
Pharmacy | 1 | 2022 | 91 | 0.190 |
Why?
|
Ambulatory Care | 3 | 2024 | 2708 | 0.190 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2018 | 2026 | 0.190 |
Why?
|
Health Promotion | 1 | 2013 | 2205 | 0.190 |
Why?
|
Nutrition Disorders | 1 | 2021 | 211 | 0.190 |
Why?
|
Cyclopropanes | 1 | 2022 | 416 | 0.190 |
Why?
|
Leucine | 1 | 2022 | 561 | 0.180 |
Why?
|
Lactams, Macrocyclic | 1 | 2022 | 320 | 0.180 |
Why?
|
Proline | 1 | 2022 | 458 | 0.180 |
Why?
|
Prospective Studies | 7 | 2022 | 53280 | 0.180 |
Why?
|
Death, Sudden | 1 | 2022 | 302 | 0.180 |
Why?
|
Senegal | 1 | 2020 | 294 | 0.180 |
Why?
|
Quinoxalines | 1 | 2022 | 290 | 0.180 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2021 | 941 | 0.180 |
Why?
|
Nepal | 1 | 2020 | 295 | 0.170 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2018 | 1320 | 0.170 |
Why?
|
Colistin | 1 | 2019 | 47 | 0.170 |
Why?
|
Quality Improvement | 2 | 2015 | 3746 | 0.170 |
Why?
|
Hospitals, Rural | 2 | 2020 | 172 | 0.170 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2022 | 274 | 0.170 |
Why?
|
Crohn Disease | 2 | 2022 | 2303 | 0.160 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2021 | 567 | 0.160 |
Why?
|
Female | 30 | 2022 | 380197 | 0.160 |
Why?
|
Africa | 2 | 2023 | 673 | 0.160 |
Why?
|
Haiti | 1 | 2020 | 553 | 0.160 |
Why?
|
Klebsiella Infections | 1 | 2019 | 138 | 0.160 |
Why?
|
Seroepidemiologic Studies | 4 | 2023 | 402 | 0.160 |
Why?
|
Infant, Newborn | 7 | 2022 | 25618 | 0.160 |
Why?
|
Klebsiella pneumoniae | 1 | 2019 | 251 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 392 | 0.150 |
Why?
|
Adolescent | 14 | 2022 | 85759 | 0.150 |
Why?
|
Aspartate Aminotransferases | 1 | 2018 | 418 | 0.150 |
Why?
|
Nutrition Surveys | 1 | 2023 | 1660 | 0.140 |
Why?
|
Case Management | 1 | 2018 | 286 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 11732 | 0.140 |
Why?
|
Surgical Equipment | 1 | 2016 | 57 | 0.140 |
Why?
|
Refugees | 1 | 2023 | 511 | 0.140 |
Why?
|
Safe Sex | 1 | 2017 | 141 | 0.140 |
Why?
|
Urinary Tract Infections | 1 | 2022 | 788 | 0.140 |
Why?
|
Alanine Transaminase | 1 | 2018 | 592 | 0.140 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 25043 | 0.140 |
Why?
|
Tanzania | 1 | 2020 | 1346 | 0.140 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2018 | 254 | 0.140 |
Why?
|
Treatment Failure | 1 | 2022 | 2619 | 0.130 |
Why?
|
Referral and Consultation | 2 | 2020 | 3528 | 0.130 |
Why?
|
Prevalence | 6 | 2023 | 15226 | 0.130 |
Why?
|
Thymidine | 1 | 2015 | 310 | 0.130 |
Why?
|
Male | 22 | 2023 | 350027 | 0.130 |
Why?
|
Treatment Outcome | 7 | 2021 | 63119 | 0.130 |
Why?
|
Health Status Indicators | 1 | 2021 | 969 | 0.130 |
Why?
|
India | 4 | 2024 | 2199 | 0.130 |
Why?
|
Middle Aged | 17 | 2022 | 213367 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2022 | 972 | 0.130 |
Why?
|
Community Health Services | 2 | 2018 | 650 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 687 | 0.120 |
Why?
|
Endemic Diseases | 1 | 2015 | 182 | 0.120 |
Why?
|
Qualitative Research | 2 | 2020 | 2682 | 0.120 |
Why?
|
World Health Organization | 2 | 2017 | 1318 | 0.120 |
Why?
|
Infant, Low Birth Weight | 1 | 2018 | 850 | 0.120 |
Why?
|
Syphilis | 1 | 2016 | 227 | 0.120 |
Why?
|
Young Adult | 13 | 2023 | 56436 | 0.110 |
Why?
|
Infant, Newborn, Diseases | 1 | 2018 | 582 | 0.110 |
Why?
|
Health Resources | 2 | 2017 | 911 | 0.110 |
Why?
|
Survival | 1 | 2013 | 163 | 0.110 |
Why?
|
Health Services | 1 | 2017 | 758 | 0.110 |
Why?
|
Sulfonamides | 1 | 2022 | 1940 | 0.110 |
Why?
|
Infant | 7 | 2020 | 35129 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 1400 | 0.100 |
Why?
|
Food Supply | 1 | 2018 | 524 | 0.100 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.100 |
Why?
|
Multilocus Sequence Typing | 2 | 2021 | 100 | 0.090 |
Why?
|
Risk Factors | 8 | 2021 | 72280 | 0.090 |
Why?
|
Colitis, Ulcerative | 1 | 2022 | 1912 | 0.090 |
Why?
|
RNA, Viral | 1 | 2018 | 2902 | 0.090 |
Why?
|
HIV-1 | 2 | 2018 | 6938 | 0.090 |
Why?
|
Child, Preschool | 5 | 2020 | 40992 | 0.090 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2559 | 0.090 |
Why?
|
Retrospective Studies | 11 | 2023 | 77426 | 0.090 |
Why?
|
Social Support | 2 | 2018 | 2117 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7784 | 0.090 |
Why?
|
Chronic Disease | 3 | 2023 | 9147 | 0.090 |
Why?
|
Health Services Needs and Demand | 2 | 2016 | 1411 | 0.090 |
Why?
|
Hepatitis C Antibodies | 2 | 2019 | 145 | 0.090 |
Why?
|
Infant, Premature | 1 | 2018 | 2044 | 0.080 |
Why?
|
Hypertension | 3 | 2024 | 8480 | 0.080 |
Why?
|
Sepsis | 1 | 2022 | 2593 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2265 | 0.080 |
Why?
|
Health Policy | 2 | 2018 | 2661 | 0.080 |
Why?
|
Pregnancy | 5 | 2022 | 29142 | 0.080 |
Why?
|
Insurance, Health | 2 | 2017 | 2494 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2022 | 2425 | 0.080 |
Why?
|
Parents | 2 | 2018 | 3407 | 0.070 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1737 | 0.070 |
Why?
|
Mass Screening | 2 | 2019 | 5252 | 0.070 |
Why?
|
Registries | 1 | 2022 | 8090 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 1999 | 0.070 |
Why?
|
Politics | 2 | 2024 | 791 | 0.070 |
Why?
|
Aged | 7 | 2022 | 163253 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2016 | 1875 | 0.060 |
Why?
|
Medication Adherence | 1 | 2016 | 2062 | 0.060 |
Why?
|
Communication | 1 | 2017 | 3749 | 0.060 |
Why?
|
Klebsiella | 1 | 2022 | 48 | 0.050 |
Why?
|
Blood Banks | 1 | 2023 | 110 | 0.050 |
Why?
|
Sierra Leone | 1 | 2023 | 166 | 0.050 |
Why?
|
Quality of Health Care | 2 | 2018 | 4371 | 0.050 |
Why?
|
Ghana | 1 | 2023 | 286 | 0.050 |
Why?
|
Tunisia | 1 | 2020 | 33 | 0.050 |
Why?
|
Vital Signs | 1 | 2022 | 141 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2013 | 3395 | 0.050 |
Why?
|
United States | 3 | 2023 | 69867 | 0.050 |
Why?
|
Guatemala | 1 | 2021 | 142 | 0.050 |
Why?
|
Egypt | 1 | 2020 | 100 | 0.050 |
Why?
|
Diabetes Mellitus | 2 | 2020 | 5755 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2018 | 21752 | 0.050 |
Why?
|
Chile | 1 | 2021 | 237 | 0.050 |
Why?
|
Retreatment | 1 | 2022 | 610 | 0.050 |
Why?
|
Disk Diffusion Antimicrobial Tests | 1 | 2019 | 9 | 0.050 |
Why?
|
Logistic Models | 3 | 2019 | 13409 | 0.040 |
Why?
|
Quality of Life | 1 | 2020 | 12805 | 0.040 |
Why?
|
Medicaid | 2 | 2022 | 2736 | 0.040 |
Why?
|
Bacterial Typing Techniques | 1 | 2019 | 256 | 0.040 |
Why?
|
Policy Making | 1 | 2023 | 554 | 0.040 |
Why?
|
Child | 4 | 2022 | 77679 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4463 | 0.040 |
Why?
|
Social Control Policies | 1 | 2017 | 9 | 0.040 |
Why?
|
Directly Observed Therapy | 1 | 2018 | 137 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12244 | 0.030 |
Why?
|
Hepatitis B e Antigens | 1 | 2015 | 133 | 0.030 |
Why?
|
Remission Induction | 1 | 2020 | 2389 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 441 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2015 | 305 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 722 | 0.030 |
Why?
|
Sentinel Surveillance | 1 | 2016 | 281 | 0.030 |
Why?
|
Population Density | 1 | 2014 | 196 | 0.030 |
Why?
|
Disease Management | 2 | 2015 | 2458 | 0.030 |
Why?
|
Professional-Family Relations | 1 | 2017 | 482 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
Community Health Centers | 1 | 2016 | 428 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2886 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2017 | 853 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2022 | 6485 | 0.020 |
Why?
|
Social Stigma | 1 | 2018 | 701 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21672 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2017 | 624 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3278 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20817 | 0.020 |
Why?
|
Prenatal Care | 1 | 2016 | 1092 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2018 | 2050 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 2796 | 0.020 |
Why?
|
Heart Failure | 2 | 2021 | 10905 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3336 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5102 | 0.020 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15538 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13990 | 0.010 |
Why?
|
Insulin | 1 | 2015 | 6583 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 9960 | 0.010 |
Why?
|
Hospitalization | 1 | 2016 | 10262 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39045 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40063 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57768 | 0.010 |
Why?
|
Concepts
(219)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_